Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002132891 | SCV002436758 | likely benign | not provided | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002132891 | SCV002569840 | uncertain significance | not provided | 2023-04-07 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In-frame insertion of 2 amino acids in a repeat region |
Ambry Genetics | RCV003061748 | SCV003540801 | likely benign | Inborn genetic diseases | 2022-11-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003913802 | SCV004732171 | likely benign | PTPN23-related disorder | 2019-05-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |